FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE was reported 43081 times

These side effects are most commonly reported by patients taking FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE:

# Side effect Count
0 DYSPNOEA 6025
1 DRUG INEFFECTIVE 3674
2 PRODUCT DOSE OMISSION ISSUE 3485
3 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3401
4 PRODUCT COMPLAINT 3063
5 COUGH 3012
6 DEATH 2401
7 PNEUMONIA 2203
8 ASTHMA 1886
9 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1648
10 FATIGUE 1468
11 OFF LABEL USE 1436
12 PRODUCT USE IN UNAPPROVED INDICATION 1422
13 HEADACHE 1420
14 DYSPHONIA 1190
15 CONDITION AGGRAVATED 1152
16 NAUSEA 1136
17 HOSPITALISATION 1036
18 DIZZINESS 1020
19 DIARRHOEA 992
20 WHEEZING 989
21 INCORRECT DOSE ADMINISTERED 988
22 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 955
23 PRODUCTIVE COUGH 946
24 MALAISE 888
25 ARTHRALGIA 870
26 FALL 859
27 PAIN 822
28 ASTHENIA 806
29 COVID-19 806
30 PRODUCT DISPENSING ERROR 725
31 CHEST DISCOMFORT 707
32 ILLNESS 698
33 BACK PAIN 688
34 VOMITING 645
35 PAIN IN EXTREMITY 623
36 EXTRA DOSE ADMINISTERED 615
37 PRODUCT USE ISSUE 611
38 PRURITUS 601
39 RASH 593
40 OROPHARYNGEAL PAIN 591
41 ANXIETY 574
42 OXYGEN SATURATION DECREASED 572
43 NASOPHARYNGITIS 563
44 INJECTION SITE PAIN 555
45 CONSTIPATION 541
46 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 532
47 CHEST PAIN 518
48 LUNG DISORDER 517
49 DYSPNOEA EXERTIONAL 512
50 WEIGHT DECREASED 496
51 HYPERTENSION 482
52 CANDIDA INFECTION 470
53 SINUSITIS 466
54 INSOMNIA 453
55 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 451
56 FEELING ABNORMAL 447
57 PERIPHERAL SWELLING 445
58 DEVICE USE ERROR 442
59 URINARY TRACT INFECTION 442
60 BRONCHITIS 440
61 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 439
62 OVERDOSE 436
63 INFLUENZA 428
64 PYREXIA 428
65 DECREASED APPETITE 403
66 DRY MOUTH 402
67 VISION BLURRED 398
68 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 394
69 RHINORRHOEA 389
70 GAIT DISTURBANCE 375
71 THROAT IRRITATION 373
72 TREMOR 364
73 ABDOMINAL PAIN 362
74 MUSCLE SPASMS 360
75 BLOOD PRESSURE INCREASED 359
76 PRODUCT DOSE OMISSION 349
77 THROMBOSIS 349
78 DEPRESSION 347
79 SOMNOLENCE 346
80 HEART RATE INCREASED 338
81 ABDOMINAL PAIN UPPER 337
82 LUNG NEOPLASM MALIGNANT 336
83 HYPERSENSITIVITY 329
84 WEIGHT INCREASED 324
85 ATRIAL FIBRILLATION 320
86 DRUG HYPERSENSITIVITY 319
87 PRODUCT STORAGE ERROR 319
88 SEPSIS 315
89 MYOCARDIAL INFARCTION 314
90 NASAL CONGESTION 311
91 ABDOMINAL DISTENSION 310
92 SLEEP DISORDER 310
93 HAEMOPTYSIS 308
94 HYPOTENSION 293
95 INFECTION 290
96 PULMONARY EMBOLISM 271
97 INTENTIONAL PRODUCT MISUSE 267
98 PALPITATIONS 267
99 CEREBROVASCULAR ACCIDENT 266
100 HYPOXIA 261
101 LOWER RESPIRATORY TRACT INFECTION 261
102 CARDIAC DISORDER 256
103 VISUAL IMPAIRMENT 256
104 PULMONARY FIBROSIS 254
105 OBSTRUCTIVE AIRWAYS DISORDER 252
106 MYALGIA 251
107 UPPER RESPIRATORY TRACT INFECTION 251
108 STRESS 244
109 ABDOMINAL DISCOMFORT 243
110 ANAEMIA 240
111 FULL BLOOD COUNT ABNORMAL 239
112 DRUG INTOLERANCE 235
113 URTICARIA 235
114 DIABETES MELLITUS 234
115 GENERAL PHYSICAL HEALTH DETERIORATION 234
116 ORAL CANDIDIASIS 233
117 UNDERDOSE 233
118 URINARY RETENTION 233
119 INTENTIONAL DOSE OMISSION 232
120 OEDEMA PERIPHERAL 232
121 SWELLING 230
122 THERAPY INTERRUPTED 230
123 PRODUCT DOSE OMISSION IN ERROR 225
124 NO ADVERSE EVENT 218
125 CARDIAC FAILURE CONGESTIVE 217
126 PRODUCT PRESCRIBING ERROR 217
127 ACCIDENTAL EXPOSURE TO PRODUCT 216
128 SECRETION DISCHARGE 216
129 DRUG DOSE OMISSION BY DEVICE 215
130 EPISTAXIS 214
131 PRODUCT LABEL CONFUSION 210
132 RESPIRATORY SYMPTOM 202
133 ERYTHEMA 201
134 PRODUCT CONFUSION 200
135 HYPONATRAEMIA 198
136 SEASONAL ALLERGY 198
137 APHONIA 197
138 GASTROOESOPHAGEAL REFLUX DISEASE 197
139 EYE PAIN 196
140 JOINT SWELLING 196
141 CHILLS 195
142 RESPIRATORY TRACT INFECTION 195
143 CONTUSION 192
144 ACUTE KIDNEY INJURY 190
145 CHOKING 187
146 DRY SKIN 186
147 EXPOSURE VIA SKIN CONTACT 183
148 DYSURIA 182
149 NEOPLASM MALIGNANT 182
150 DRY EYE 181
151 IMPAIRED QUALITY OF LIFE 181
152 VASCULITIS 180
153 BLOOD GLUCOSE INCREASED 179
154 MEMORY IMPAIRMENT 178
155 ALOPECIA 177
156 CONFUSIONAL STATE 177
157 LOSS OF CONSCIOUSNESS 176
158 PULMONARY CONGESTION 175
159 DEHYDRATION 172
160 ADVERSE DRUG REACTION 171
161 BLOOD PRESSURE DECREASED 171
162 HYPOAESTHESIA 170
163 RESPIRATORY TRACT CONGESTION 169
164 SURGERY 167
165 DEVICE DELIVERY SYSTEM ISSUE 166
166 SKIN EXFOLIATION 166
167 CATARACT 165
168 DYSPEPSIA 165
169 INJECTION SITE ERYTHEMA 165
170 GASTROINTESTINAL DISORDER 162
171 HYPOTHYROIDISM 162
172 MUSCULAR WEAKNESS 161
173 HOSPICE CARE 160
174 FLUID RETENTION 158
175 NEURITIS 157
176 PULMONARY ALVEOLAR HAEMORRHAGE 157
177 ARTHRITIS 156
178 NEUROLOGICAL SYMPTOM 156
179 CARDIOGENIC SHOCK 155
180 PRODUCT PRESCRIBING ISSUE 155
181 PULMONARY VASCULITIS 155
182 ASCITES 154
183 POLLAKIURIA 153
184 DYSGEUSIA 151
185 SINUS DISORDER 150
186 SPUTUM DISCOLOURED 150
187 BACTERIAL INFECTION 149
188 ILL-DEFINED DISORDER 149
189 BLOOD CHOLESTEROL INCREASED 148
190 MULTIPLE ORGAN DYSFUNCTION SYNDROME 148
191 MUSCULOSKELETAL STIFFNESS 147
192 NERVOUSNESS 147
193 PLEURAL EFFUSION 147
194 RESPIRATORY FAILURE 146
195 EMPHYSEMA 145
196 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 145
197 APPENDICITIS 144
198 RESPIRATORY DISORDER 144
199 CARDIAC FAILURE 143
200 PULMONARY MASS 143
201 EXPIRED PRODUCT ADMINISTERED 142
202 PARAESTHESIA 142
203 TASTE DISORDER 140
204 THERAPEUTIC RESPONSE UNEXPECTED 140
205 APPENDICOLITH 138
206 DYSPHAGIA 138
207 MIGRAINE 138
208 PULMONARY OEDEMA 138
209 TREATMENT NONCOMPLIANCE 138
210 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 137
211 HOT FLUSH 134
212 THERAPY NON-RESPONDER 134
213 INABILITY TO AFFORD MEDICATION 132
214 BALANCE DISORDER 131
215 HYPERHIDROSIS 131
216 INJECTION SITE SWELLING 130
217 HIP FRACTURE 129
218 VENTRICULAR FIBRILLATION 129
219 NEURALGIA 127
220 THERAPY CESSATION 127
221 NECK PAIN 126
222 STOMATITIS 126
223 BLOOD PHOSPHORUS INCREASED 125
224 ARTERIOSCLEROSIS CORONARY ARTERY 124
225 GOUT 124
226 EYE IRRITATION 123
227 NODULE 123
228 THERAPEUTIC RESPONSE SHORTENED 123
229 EYE PRURITUS 122
230 DRUG EFFECT LESS THAN EXPECTED 121
231 ARTERIOSCLEROSIS 120
232 INSURANCE ISSUE 120
233 DUST ALLERGY 119
234 RETCHING 118
235 INJECTION SITE BRUISING 117
236 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 116
237 MYCOTIC ALLERGY 115
238 ORAL PAIN 115
239 TACHYCARDIA 112
240 CONJUNCTIVITIS ALLERGIC 111
241 MITE ALLERGY 111
242 MYASTHENIA GRAVIS 111
243 VIRAL INFECTION 111
244 NORMOCHROMIC NORMOCYTIC ANAEMIA 110
245 AGEUSIA 108
246 BLOOD CREATININE INCREASED 108
247 RASH PRURITIC 108
248 SNEEZING 108
249 SPIROMETRY ABNORMAL 108
250 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 107
251 HERPES ZOSTER 107
252 INFLUENZA LIKE ILLNESS 106
253 INFUSION SITE PAIN 106
254 MIDDLE INSOMNIA 106
255 BLOOD URIC ACID INCREASED 105
256 SYNCOPE 105
257 TOTAL LUNG CAPACITY ABNORMAL 104
258 DRUG INTERACTION 103
259 FORCED EXPIRATORY VOLUME DECREASED 103
260 MULTIPLE ALLERGIES 103
261 SEIZURE 102
262 DEVICE ISSUE 101
263 GAIT INABILITY 101
264 NEUROPATHY PERIPHERAL 101
265 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 101
266 INCREASED BRONCHIAL SECRETION 100
267 OROPHARYNGEAL DISCOMFORT 100
268 RENAL FAILURE 100
269 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 99
270 INJECTION SITE PRURITUS 99
271 LIMB INJURY 99
272 OSTEOPOROSIS 99
273 DRY THROAT 98
274 FUNGAL INFECTION 98
275 SPEECH DISORDER 98
276 MOBILITY DECREASED 97
277 CELLULITIS 95
278 EYE DISORDER 95
279 HYPOACUSIS 95
280 RIB FRACTURE 95
281 SWELLING FACE 95
282 THERAPEUTIC RESPONSE DECREASED 95
283 ULCER 95
284 END STAGE RENAL DISEASE 94
285 FLATULENCE 94
286 HYPERLIPIDAEMIA 94
287 DISCOMFORT 93
288 FLUSHING 93
289 HYPOPHOSPHATAEMIA 93
290 LARYNGITIS 93
291 ANALGESIC THERAPY 91
292 BONE PAIN 91
293 BRONCHIECTASIS 91
294 DEVICE MALFUNCTION 90
295 DIVERTICULITIS 90
296 DRUG THERAPY 89
297 DEPRESSED MOOD 88
298 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 88
299 HYPERPHOSPHATAEMIA 88
300 LACRIMATION INCREASED 88
301 PANIC ATTACK 88
302 THERAPEUTIC PRODUCT EFFECT DECREASED 88
303 ECZEMA 87
304 HEAD INJURY 87
305 BURNING SENSATION 86
306 AMNESIA 85
307 ANAPHYLACTIC REACTION 85
308 OCULAR HYPERAEMIA 85
309 ORAL DISCOMFORT 85
310 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 84
311 RHEUMATOID ARTHRITIS 83
312 HALLUCINATION 82
313 SWOLLEN TONGUE 82
314 VERTIGO 82
315 CYSTITIS 81
316 UNEVALUABLE EVENT 81
317 UPPER-AIRWAY COUGH SYNDROME 81
318 BLOOD TEST ABNORMAL 80
319 BREAST CANCER 80
320 EAR INFECTION 80
321 JOINT INJURY 80
322 LETHARGY 80
323 PSORIASIS 79
324 INFUSION SITE ERYTHEMA 78
325 IRON DEFICIENCY 78
326 PRESCRIBED OVERDOSE 78
327 ACUTE RESPIRATORY FAILURE 77
328 AORTIC STENOSIS 77
329 DRUG DISPENSING ERROR 77
330 BLOOD CALCIUM INCREASED 76
331 DEMENTIA 76
332 GLAUCOMA 76
333 INTERSTITIAL LUNG DISEASE 76
334 RESPIRATION ABNORMAL 76
335 ASPARTATE AMINOTRANSFERASE INCREASED 75
336 PNEUMOTHORAX 75
337 SLEEP DISORDER THERAPY 75
338 BLOOD PRESSURE ABNORMAL 74
339 PHARYNGEAL SWELLING 74
340 PRODUCT PACKAGING CONFUSION 74
341 NEPHROLITHIASIS 73
342 RASH MACULAR 73
343 CORONARY ARTERY DISEASE 72
344 FEELING HOT 72
345 PRODUCT QUALITY ISSUE 72
346 DERMATITIS ATOPIC 71
347 LIP SWELLING 71
348 OEDEMA 71
349 TROPONIN INCREASED 71
350 HAEMOGLOBIN DECREASED 70
351 SPINAL FRACTURE 70
352 TOTAL LUNG CAPACITY DECREASED 70
353 ARRHYTHMIA 69
354 INTENTIONAL UNDERDOSE 69
355 THROAT TIGHTNESS 69
356 CAPILLARITIS 68
357 PNEUMONIA BACTERIAL 68
358 RENAL DISORDER 68
359 SINUS CONGESTION 68
360 SKIN DISCOLOURATION 68
361 ASPIRATION 67
362 BLISTER 67
363 PULMONARY HYPERTENSION 67
364 BREATH SOUNDS ABNORMAL 66
365 CARDIAC ARREST 66
366 FEELING JITTERY 66
367 HEART RATE DECREASED 66
368 INFUSION SITE SWELLING 66
369 INTENTIONAL PRODUCT USE ISSUE 66
370 OXYGEN SATURATION ABNORMAL 65
371 TRANSIENT ISCHAEMIC ATTACK 65
372 ANTACID THERAPY 64
373 ANTICOAGULANT THERAPY 64
374 CARDIAC OPERATION 64
375 EMOTIONAL DISTRESS 64
376 HYPERSOMNIA 64
377 PLATELET COUNT DECREASED 64
378 INCORRECT DOSE ADMINISTERED BY DEVICE 63
379 OSTEOARTHRITIS 63
380 PULMONARY PAIN 62
381 ROAD TRAFFIC ACCIDENT 62
382 SLEEP APNOEA SYNDROME 62
383 ARTHROPATHY 61
384 GLOSSODYNIA 61
385 IMPAIRED GASTRIC EMPTYING 61
386 OCULAR DISCOMFORT 61
387 URINARY INCONTINENCE 61
388 INJECTION SITE REACTION 60
389 KNEE ARTHROPLASTY 60
390 MICTURITION URGENCY 60
391 HAEMORRHAGE 59
392 OXYGEN THERAPY 59
393 BLOOD SODIUM DECREASED 58
394 BRONCHOSPASM 58
395 COVID-19 PNEUMONIA 58
396 DISEASE PROGRESSION 58
397 HIP ARTHROPLASTY 58
398 INTESTINAL OBSTRUCTION 58
399 MENTAL DISORDER 58
400 NEUTROPENIA 58
401 TINNITUS 58
402 EAR PAIN 57
403 INFUSION RELATED REACTION 57
404 LOWER LIMB FRACTURE 57
405 RESPIRATORY SYNCYTIAL VIRUS INFECTION 57
406 WHITE BLOOD CELL COUNT DECREASED 57
407 BRADYCARDIA 56
408 INJECTION SITE RASH 56
409 OBSTRUCTION 56
410 RASH ERYTHEMATOUS 56
411 SPUTUM INCREASED 56
412 BLOOD POTASSIUM DECREASED 55
413 BRAIN FOG 55
414 EYE SWELLING 55
415 LIVER DISORDER 55
416 LIVER FUNCTION TEST INCREASED 55
417 MENTAL IMPAIRMENT 55
418 PAIN IN JAW 55
419 PNEUMONITIS 55
420 TOOTHACHE 55
421 ACCIDENTAL OVERDOSE 54
422 DEVICE USE ISSUE 54
423 HEART RATE IRREGULAR 54
424 SKIN LACERATION 54
425 SPINAL OPERATION 54
426 ADVERSE EVENT 53
427 ANKLE FRACTURE 53
428 CHOKING SENSATION 53
429 HERNIA 53
430 PRODUCT PREPARATION ERROR 53
431 UPPER LIMB FRACTURE 53
432 BLINDNESS 52
433 CORONAVIRUS INFECTION 52
434 INFLAMMATION 52
435 ORAL HERPES 52
436 COLITIS 51
437 DISEASE RECURRENCE 51
438 LUNG OPACITY 51
439 GASTROINTESTINAL HAEMORRHAGE 50
440 LABELLED DRUG-DRUG INTERACTION ISSUE 50
441 LOCALISED INFECTION 50
442 MUSCULOSKELETAL CHEST PAIN 50
443 POOR QUALITY SLEEP 50
444 RESPIRATORY DISTRESS 50
445 WHITE BLOOD CELL COUNT INCREASED 50
446 CHRONIC KIDNEY DISEASE 49
447 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 49
448 MACULAR DEGENERATION 49
449 NIGHT SWEATS 49
450 SUICIDAL IDEATION 49
451 FOOT FRACTURE 48
452 PULMONARY FUNCTION TEST DECREASED 48
453 DISTURBANCE IN ATTENTION 47
454 FOREIGN BODY IN THROAT 47
455 HAEMATOCHEZIA 47
456 PRODUCT COMMUNICATION ISSUE 47
457 PROSTATE CANCER 47
458 RALES 47
459 ANGINA PECTORIS 46
460 BLOOD PRESSURE FLUCTUATION 46
461 FEEDING DISORDER 46
462 GASTROENTERITIS VIRAL 46
463 RENAL IMPAIRMENT 46
464 BACK DISORDER 45
465 BENIGN PROSTATIC HYPERPLASIA 45
466 BLOOD GLUCOSE DECREASED 45
467 CARDIAC PACEMAKER INSERTION 45
468 INFUSION SITE HAEMORRHAGE 45
469 INITIAL INSOMNIA 45
470 LUNG INFECTION 45
471 MUSCULOSKELETAL DISCOMFORT 45
472 PRODUCT USE COMPLAINT 45
473 CONTRAINDICATED PRODUCT ADMINISTERED 44
474 FEELING COLD 44
475 PNEUMONIA ASPIRATION 44
476 THROAT CLEARING 44
477 DERMATITIS CONTACT 43
478 DISABILITY 43
479 EOSINOPHILIA 43
480 LIMB DISCOMFORT 43
481 PRODUCT TASTE ABNORMAL 43
482 AGITATION 42
483 INJECTION SITE HAEMORRHAGE 42
484 OXYGEN CONSUMPTION INCREASED 42
485 SKIN DISORDER 42
486 STAPHYLOCOCCAL INFECTION 42
487 PRODUCT ADMINISTRATION ERROR 41
488 PULMONARY THROMBOSIS 41
489 RESTLESS LEGS SYNDROME 41
490 SCIATICA 41
491 DEVICE DEPOSIT ISSUE 40
492 PERICARDIAL EFFUSION 40
493 BACTEROIDES INFECTION 39
494 DEVICE DISPENSING ERROR 39
495 HYPERVOLAEMIA 39
496 LYMPHADENOPATHY 39
497 PRODUCT RESIDUE PRESENT 39
498 SARS-COV-2 TEST POSITIVE 39
499 SKIN FISSURES 39
500 CHOLELITHIASIS 38
501 HEAD DISCOMFORT 38
502 INCORRECT PRODUCT ADMINISTRATION DURATION 38
503 JOINT STIFFNESS 38
504 MOVEMENT DISORDER 38
505 POST PROCEDURAL COMPLICATION 38
506 PRODUCT ADMINISTRATION INTERRUPTED 38
507 QUALITY OF LIFE DECREASED 38
508 SKIN CANCER 38
509 SYSTEMIC LUPUS ERYTHEMATOSUS 38
510 THROMBOCYTOPENIA 38
511 BLADDER CANCER 37
512 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 37
513 DEAFNESS 37
514 DECREASED ACTIVITY 37
515 HEPATIC ENZYME INCREASED 37
516 PRODUCT AVAILABILITY ISSUE 37
517 PRODUCT SELECTION ERROR 37
518 SEPTIC SHOCK 37
519 TRANSAMINASES INCREASED 37
520 WRIST FRACTURE 37
521 DIPLOPIA 36
522 INFUSION SITE DISCHARGE 36
523 INJECTION SITE MASS 36
524 NASAL DRYNESS 36
525 NEEDLE ISSUE 36
526 ORAL MUCOSAL BLISTERING 36
527 PHARYNGITIS 36
528 TONGUE DISCOMFORT 36
529 ANOSMIA 35
530 APHASIA 35
531 CLOSTRIDIUM DIFFICILE INFECTION 35
532 DEVICE LEAKAGE 35
533 HAEMATEMESIS 35
534 INFUSION SITE PRURITUS 35
535 MALIGNANT NEOPLASM PROGRESSION 35
536 STENT PLACEMENT 35
537 DEEP VEIN THROMBOSIS 34
538 DYSSTASIA 34
539 PANCREATITIS 34
540 PRESYNCOPE 34
541 PSORIATIC ARTHROPATHY 34
542 ROTATOR CUFF SYNDROME 34
543 SKIN BURNING SENSATION 34
544 SKIN LESION 34
545 THIRST 34
546 BLOOD PRESSURE SYSTOLIC INCREASED 33
547 CONGENITAL HIATUS HERNIA 33
548 EATING DISORDER 33
549 HYPOAESTHESIA ORAL 33
550 HYPOPHAGIA 33
551 INFUSION SITE BRUISING 33
552 INJURY 33
553 INTERCEPTED MEDICATION ERROR 33
554 IRON DEFICIENCY ANAEMIA 33
555 IRRITABILITY 33
556 KIDNEY INFECTION 33
557 NOCTURIA 33
558 OESOPHAGEAL CANDIDIASIS 33
559 ORTHOSTATIC HYPOTENSION 33
560 POOR VENOUS ACCESS 33
561 RHINITIS ALLERGIC 33
562 CARDIOVASCULAR DISORDER 32
563 CATARACT OPERATION 32
564 CONJUNCTIVITIS 32
565 DEVICE INFUSION ISSUE 32
566 DIZZINESS POSTURAL 32
567 GASTRITIS 32
568 HEART RATE ABNORMAL 32
569 HIATUS HERNIA 32
570 HYPERKALAEMIA 32
571 PARANASAL SINUS DISCOMFORT 32
572 PLEURITIC PAIN 32
573 PRODUCT SUBSTITUTION ISSUE 32
574 SCAR 32
575 BLOOD URINE PRESENT 31
576 BODY TEMPERATURE INCREASED 31
577 BREAST CONSERVING SURGERY 31
578 DEVICE USE CONFUSION 31
579 MALIGNANT MELANOMA STAGE 0 31
580 NEAR DEATH EXPERIENCE 31
581 PATIENT DISSATISFACTION WITH TREATMENT 31
582 PRODUCT DISTRIBUTION ISSUE 31
583 RHINITIS 31
584 SCRATCH 31
585 TONGUE COATED 31
586 BACK INJURY 30
587 EOSINOPHIL COUNT INCREASED 30
588 ERUCTATION 30
589 KNEE OPERATION 30
590 MUSCLE STRAIN 30
591 PHOTOPHOBIA 30
592 PROCEDURAL PAIN 30
593 ANGIOEDEMA 29
594 EAR DISCOMFORT 29
595 HYPERCHOLESTEROLAEMIA 29
596 HYPOKALAEMIA 29
597 INCREASED UPPER AIRWAY SECRETION 29
598 MOUTH ULCERATION 29
599 MYCOBACTERIUM AVIUM COMPLEX INFECTION 29
600 PRODUCT STORAGE ISSUE 29
601 SENSITIVITY TO WEATHER CHANGE 29
602 SKIN HAEMORRHAGE 29
603 THYROID DISORDER 29
604 BLOOD COUNT ABNORMAL 28
605 CEREBRAL HAEMORRHAGE 28
606 COLON CANCER 28
607 EYE INFECTION 28
608 FREQUENT BOWEL MOVEMENTS 28
609 FULL BLOOD COUNT DECREASED 28
610 INJECTION SITE URTICARIA 28
611 INTENTIONAL OVERDOSE 28
612 IRRITABLE BOWEL SYNDROME 28
613 MUSCULOSKELETAL PAIN 28
614 PSEUDOMONAS INFECTION 28
615 REHABILITATION THERAPY 28
616 SUFFOCATION FEELING 28
617 THERAPY CHANGE 28
618 URINE FLOW DECREASED 28
619 WEIGHT FLUCTUATION 28
620 WOUND 28
621 DEVICE DIFFICULT TO USE 27
622 DEVICE OCCLUSION 27
623 DRUG EFFECT INCOMPLETE 27
624 HYPOMAGNESAEMIA 27
625 IMMUNE SYSTEM DISORDER 27
626 POOR QUALITY PRODUCT ADMINISTERED 27
627 RESTLESSNESS 27
628 SYMPTOM RECURRENCE 27
629 TONGUE DISCOLOURATION 27
630 AORTIC ANEURYSM 26
631 CARPAL TUNNEL SYNDROME 26
632 CROHN^S DISEASE 26
633 EYE HAEMORRHAGE 26
634 FIBROMYALGIA 26
635 FOREIGN BODY SENSATION IN EYES 26
636 IMMUNODEFICIENCY 26
637 LABORATORY TEST ABNORMAL 26
638 LIGAMENT SPRAIN 26
639 NIGHTMARE 26
640 ORAL DISORDER 26
641 PARAESTHESIA ORAL 26
642 RECTAL HAEMORRHAGE 26
643 RESPIRATORY RATE INCREASED 26
644 SKIN SWELLING 26
645 TENDONITIS 26
646 TYPE 2 DIABETES MELLITUS 26
647 ABNORMAL DREAMS 25
648 ACCIDENT 25
649 ALANINE AMINOTRANSFERASE INCREASED 25
650 ASTHMATIC CRISIS 25
651 BLINDNESS UNILATERAL 25
652 CHOLECYSTECTOMY 25
653 CHROMATURIA 25
654 COGNITIVE DISORDER 25
655 EYE DISCHARGE 25
656 GASTROINTESTINAL INFECTION 25
657 GLYCOSYLATED HAEMOGLOBIN INCREASED 25
658 HAEMATURIA 25
659 HAEMOGLOBIN INCREASED 25
660 INCONTINENCE 25
661 INTERVERTEBRAL DISC PROTRUSION 25
662 INTRAOCULAR PRESSURE INCREASED 25
663 MUSCLE TIGHTNESS 25
664 ORAL FUNGAL INFECTION 25
665 OROPHARYNGEAL CANDIDIASIS 25
666 OSTEOPENIA 25
667 PHARYNGITIS STREPTOCOCCAL 25
668 POST PROCEDURAL INFECTION 25
669 SKIN ABRASION 25
670 SKIN INFECTION 25
671 SUSPECTED COVID-19 25
672 TOOTH DISORDER 25
673 CARDIAC FLUTTER 24
674 DYSKINESIA 24
675 FAECES DISCOLOURED 24
676 FEBRILE NEUTROPENIA 24
677 FEMUR FRACTURE 24
678 HYPERGLYCAEMIA 24
679 IMPAIRED HEALING 24
680 OBESITY 24
681 PNEUMONIA FUNGAL 24
682 RED BLOOD CELL COUNT DECREASED 24
683 RESPIRATORY TRACT IRRITATION 24
684 SKIN ULCER 24
685 VITREOUS FLOATERS 24
686 ANEURYSM 23
687 BEDRIDDEN 23
688 BLOOD IRON DECREASED 23
689 BLOOD POTASSIUM INCREASED 23
690 BODY HEIGHT DECREASED 23
691 BURSITIS 23
692 COLITIS ULCERATIVE 23
693 CORONARY ARTERY OCCLUSION 23
694 DEVICE DISLOCATION 23
695 DRUG DOSE OMISSION 23
696 DRUG TOLERANCE DECREASED 23
697 EXERCISE TOLERANCE DECREASED 23
698 FEAR 23
699 INFUSION SITE EXTRAVASATION 23
700 INTERCEPTED PRODUCT DISPENSING ERROR 23
701 LACTIC ACIDOSIS 23
702 PARANASAL SINUS HYPERSECRETION 23
703 PSYCHIATRIC SYMPTOM 23
704 RESPIRATORY ARREST 23
705 SWELLING OF EYELID 23
706 THERAPY PARTIAL RESPONDER 23
707 TOOTH ABSCESS 23
708 TOOTH INFECTION 23
709 TREATMENT FAILURE 23
710 ANAPHYLACTIC SHOCK 22
711 ARTERIAL OCCLUSIVE DISEASE 22
712 ARTHROPOD BITE 22
713 ATELECTASIS 22
714 BLOOD DISORDER 22
715 CHRONIC SINUSITIS 22
716 COMA 22
717 CONCUSSION 22
718 CYANOSIS 22
719 DECREASED INTEREST 22
720 DISORIENTATION 22
721 GINGIVAL PAIN 22
722 INTERCEPTED PRODUCT PRESCRIBING ERROR 22
723 NERVOUS SYSTEM DISORDER 22
724 OBSTRUCTIVE SLEEP APNOEA SYNDROME 22
725 PAIN OF SKIN 22
726 SENSATION OF FOREIGN BODY 22
727 SUPERFICIAL VEIN THROMBOSIS 22
728 TOOTH EXTRACTION 22
729 ACNE 21
730 ACUTE MYOCARDIAL INFARCTION 21
731 ANAL INCONTINENCE 21
732 DEVICE DEFECTIVE 21
733 EXPOSURE DURING PREGNANCY 21
734 FACIAL PAIN 21
735 GASTROINTESTINAL PAIN 21
736 GLOSSITIS 21
737 HAEMATOMA 21
738 INCREASED TENDENCY TO BRUISE 21
739 INJECTION SITE WARMTH 21
740 INTERNAL HAEMORRHAGE 21
741 LIP PAIN 21
742 MICTURITION DISORDER 21
743 MOUTH SWELLING 21
744 PERIORBITAL SWELLING 21
745 PULMONARY FUNCTION TEST ABNORMAL 21
746 TOOTH FRACTURE 21
747 URINE OUTPUT DECREASED 21
748 WALKING AID USER 21
749 ADVERSE REACTION 20
750 ATYPICAL PNEUMONIA 20
751 BRONCHITIS CHRONIC 20
752 CARBON DIOXIDE INCREASED 20
753 CORONARY ARTERIAL STENT INSERTION 20
754 CORONAVIRUS TEST POSITIVE 20
755 DEMENTIA ALZHEIMER^S TYPE 20
756 DIABETIC KETOACIDOSIS 20
757 EYE OPERATION 20
758 GALLBLADDER DISORDER 20
759 GASTRIC DISORDER 20
760 GLUCOSE TOLERANCE IMPAIRED 20
761 INTERCEPTED PRODUCT ADMINISTRATION ERROR 20
762 MEDICATION ERROR 20
763 MELAENA 20
764 MUSCULOSKELETAL DISORDER 20
765 NASAL POLYPS 20
766 PANIC REACTION 20
767 PNEUMONIA PSEUDOMONAL 20
768 PRODUCT PACKAGING QUANTITY ISSUE 20
769 RASH PAPULAR 20
770 RHINOVIRUS INFECTION 20
771 SENSITIVE SKIN 20
772 TENDERNESS 20
773 VOCAL CORD DISORDER 20
774 ATRIOVENTRICULAR BLOCK 19
775 BLOOD UREA INCREASED 19
776 CEREBRAL DISORDER 19
777 CHAPPED LIPS 19
778 COMPLICATION ASSOCIATED WITH DEVICE 19
779 DENTAL CARIES 19
780 DEVICE MECHANICAL ISSUE 19
781 DEVICE PHYSICAL PROPERTY ISSUE 19
782 DYSARTHRIA 19
783 GLOMERULAR FILTRATION RATE DECREASED 19
784 HIP SURGERY 19
785 HORDEOLUM 19
786 INCORRECT DRUG ADMINISTRATION RATE 19
787 INCREASED VISCOSITY OF BRONCHIAL SECRETION 19
788 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 19
789 INJECTION SITE DISCOMFORT 19
790 NASAL DISCOMFORT 19
791 NERVE COMPRESSION 19
792 PARKINSON^S DISEASE 19
793 PELVIC FRACTURE 19
794 PERIPHERAL COLDNESS 19
795 PULMONARY ARTERIAL HYPERTENSION 19
796 SKIN ATROPHY 19
797 SPUTUM RETENTION 19
798 TEMPERATURE INTOLERANCE 19
799 UNRESPONSIVE TO STIMULI 19
800 UPPER GASTROINTESTINAL HAEMORRHAGE 19
801 WOUND INFECTION 19
802 ADRENAL INSUFFICIENCY 18
803 ANGER 18
804 ANHEDONIA 18
805 CATHETERISATION CARDIAC 18
806 CHRONIC RESPIRATORY FAILURE 18
807 COATING IN MOUTH 18
808 DYSPNOEA AT REST 18
809 FOOD ALLERGY 18
810 HAEMATOLOGICAL INFECTION 18
811 HEPATIC STEATOSIS 18
812 HYPOGLYCAEMIA 18
813 INFUSION SITE MASS 18
814 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 18
815 LUNG OPERATION 18
816 NEOPLASM 18
817 PAINFUL RESPIRATION 18
818 POLYP 18
819 POOR QUALITY DEVICE USED 18
820 SNORING 18
821 SPINAL DISORDER 18
822 TONGUE BLISTERING 18
823 WRONG PRODUCT ADMINISTERED 18
824 WRONG STRENGTH 18
825 ASPERGILLUS INFECTION 17
826 CARDIO-RESPIRATORY ARREST 17
827 CONTRAINDICATED PRODUCT PRESCRIBED 17
828 CORONARY ARTERY BYPASS 17
829 DEVICE BREAKAGE 17
830 ENERGY INCREASED 17
831 EYELID MARGIN CRUSTING 17
832 FAECES SOFT 17
833 FRACTURE 17
834 GASTROENTERITIS 17
835 GENERALISED OEDEMA 17
836 INCREASED APPETITE 17
837 JOINT DISLOCATION 17
838 LIP DRY 17
839 MOOD ALTERED 17
840 NOCTURNAL DYSPNOEA 17
841 PANCYTOPENIA 17
842 PAROSMIA 17
843 PLASMA CELL MYELOMA 17
844 PRODUCT PREPARATION ISSUE 17
845 PSYCHOMOTOR HYPERACTIVITY 17
846 RHABDOMYOLYSIS 17
847 SKIN MASS 17
848 THINKING ABNORMAL 17
849 TONGUE DISORDER 17
850 ULCER HAEMORRHAGE 17
851 URINARY TRACT DISORDER 17
852 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 17
853 ABDOMINAL PAIN LOWER 16
854 ABSCESS 16
855 BRAIN NEOPLASM 16
856 CARDIOMEGALY 16
857 DELUSION 16
858 ELECTROCARDIOGRAM QT PROLONGED 16
859 ERECTILE DYSFUNCTION 16
860 FEAR OF INJECTION 16
861 FOOT OPERATION 16
862 FRUSTRATION TOLERANCE DECREASED 16
863 HAEMORRHOIDS 16
864 HALLUCINATION, VISUAL 16
865 HEPATIC CANCER 16
866 HERNIA REPAIR 16
867 HYPERCAPNIA 16
868 HYPERTHYROIDISM 16
869 HYPOGAMMAGLOBULINAEMIA 16
870 INJECTION SITE DISCHARGE 16
871 JOINT RANGE OF MOTION DECREASED 16
872 MIDDLE EAR EFFUSION 16
873 OESOPHAGITIS 16
874 PANCREATIC CARCINOMA 16
875 PANCREATITIS ACUTE 16
876 PRODUCT AFTER TASTE 16
877 PRODUCT DISPENSING ISSUE 16
878 PROSTATIC SPECIFIC ANTIGEN INCREASED 16
879 SCAB 16
880 SINUS HEADACHE 16
881 SLUGGISHNESS 16
882 SPINAL OSTEOARTHRITIS 16
883 BLADDER DISORDER 15
884 BREAST PAIN 15
885 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 15
886 CRYING 15
887 CYST 15
888 DECREASED IMMUNE RESPONSIVENESS 15
889 DELIRIUM 15
890 DEVICE POWER SOURCE ISSUE 15
891 DISEASE COMPLICATION 15
892 EMERGENCY CARE 15
893 ESSENTIAL HYPERTENSION 15
894 EXPIRED DEVICE USED 15
895 FLANK PAIN 15
896 GASTRIC INFECTION 15
897 GROIN PAIN 15
898 HAND FRACTURE 15
899 HYPOPNOEA 15
900 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 15
901 LEUKOCYTOSIS 15
902 LIMB OPERATION 15
903 LYMPHOMA 15
904 MULTIPLE FRACTURES 15
905 OSTEOMYELITIS 15
906 PNEUMONIA VIRAL 15
907 PRODUCT LEAKAGE 15
908 PRODUCT PHYSICAL ISSUE 15
909 PULMONARY HAEMORRHAGE 15
910 RHINALGIA 15
911 RHONCHI 15
912 ROSACEA 15
913 SARCOIDOSIS 15
914 TACHYPNOEA 15
915 TONGUE ERYTHEMA 15
916 TRANSFUSION 15
917 ABNORMAL BEHAVIOUR 14
918 ARTHRITIS INFECTIVE 14
919 BACTERAEMIA 14
920 BASAL CELL CARCINOMA 14
921 BLINDNESS TRANSIENT 14
922 BLOOD CALCIUM DECREASED 14
923 BLOOD GLUCOSE ABNORMAL 14
924 BLOOD MAGNESIUM DECREASED 14
925 CERVICAL VERTEBRAL FRACTURE 14
926 CHEMOTHERAPY 14
927 CHOLECYSTITIS 14
928 COLD SWEAT 14
929 DIVERTICULUM INTESTINAL 14
930 FACIAL PARALYSIS 14
931 FOOD POISONING 14
932 GINGIVITIS 14
933 HEPATIC CYTOLYSIS 14
934 HICCUPS 14
935 INFUSION SITE INDURATION 14
936 INFUSION SITE IRRITATION 14
937 INFUSION SITE WARMTH 14
938 INTERVERTEBRAL DISC DEGENERATION 14
939 LEUKAEMIA 14
940 LOWER RESPIRATORY TRACT CONGESTION 14
941 LYMPHOEDEMA 14
942 NECK INJURY 14
943 NERVE INJURY 14
944 ORAL MUCOSAL ERUPTION 14
945 PNEUMONIA INFLUENZAL 14
946 POST-ACUTE COVID-19 SYNDROME 14
947 PROSTATIC DISORDER 14
948 REBOUND EFFECT 14
949 RENAL CANCER 14
950 SHOULDER OPERATION 14
951 SINUS PAIN 14
952 SKIN IRRITATION 14
953 SPINAL STENOSIS 14
954 SUICIDE ATTEMPT 14
955 TOXICITY TO VARIOUS AGENTS 14
956 TRICUSPID VALVE INCOMPETENCE 14
957 URINE ODOUR ABNORMAL 14
958 VITAMIN D DEFICIENCY 14
959 VOCAL CORD PARALYSIS 14
960 AGGRESSION 13
961 ASBESTOSIS 13
962 BLOOD GLUCOSE FLUCTUATION 13
963 BRAIN NEOPLASM MALIGNANT 13
964 C-REACTIVE PROTEIN INCREASED 13
965 CHEILITIS 13
966 CLOSTRIDIUM DIFFICILE COLITIS 13
967 DERMATITIS 13
968 DIALYSIS 13
969 DIARRHOEA HAEMORRHAGIC 13
970 EYELID IRRITATION 13
971 GINGIVAL BLEEDING 13
972 HEREDITARY ANGIOEDEMA 13
973 HYPERVENTILATION 13
974 INFUSION SITE RASH 13
975 JOINT NOISE 13
976 LACTOSE INTOLERANCE 13
977 LIP BLISTER 13
978 NECK SURGERY 13
979 NICOTINE DEPENDENCE 13
980 PALLOR 13
981 PLEURISY 13
982 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13
983 RENAL PAIN 13
984 SUPRAVENTRICULAR TACHYCARDIA 13
985 TERMINAL STATE 13
986 THERAPEUTIC PRODUCT EFFECT DELAYED 13
987 THROAT CANCER 13
988 UPPER RESPIRATORY TRACT CONGESTION 13
989 VISUAL ACUITY REDUCED 13
990 APHTHOUS ULCER 12
991 APPETITE DISORDER 12
992 ATRIAL FLUTTER 12
993 AUTOIMMUNE DISORDER 12
994 BARRETT^S OESOPHAGUS 12
995 BONE CANCER 12
996 BRAIN INJURY 12
997 BREAST CANCER FEMALE 12
998 BREAST MASS 12
999 COLONOSCOPY 12